000 06823cam a2200421Mi 4500
001 on1267425730
003 OCoLC
005 20230606090510.0
006 m o d
007 cr cnu||||||||
008 200401s2019 xx o ||| 0 eng d
020 _a9781119328056
_q(electronic bk.)
035 _a(OCoLC)1267425730
040 _aDKU
_beng
_erda
_eaacr
_cDKU
_dOCLCO
_dOCLCF
_dOCLCO
082 _a614
_bHAW
100 1 _aHawker, Jeremy,
245 1 0 _aCommunicable disease control and health protection handbook :
_h[electronic book] /
250 _a4th ed.
264 1 _aNewark, N. J. :
_bJohn Wiley & Sons,
_c2019.
300 _a1 online resource (480 pages)
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
505 0 _aIntro -- Title Page -- Copyright Page -- Contents -- About the authors -- Foreword -- Abbreviations -- Section 1 Introduction -- 1.1 How to use this book -- 1.2 Basic concepts in the epidemiology of infectious disease -- 1.3 Basic concepts in the prevention of infection -- 1.4 Emergency risk communication -- 1.5 Health protection on-call -- Section 2 Common topics -- 2.1 Meningitis and meningism -- 2.2 Gastrointestinal infection -- 2.3 Community acquired pneumonia -- 2.4 Rash in pregnancy -- 2.5 Rash and fever in children -- 2.6 Illness in returning travellers -- 2.7 Jaundice -- 2.8 Infection in the immunocompromised -- Section 3 Diseases -- 3.1 Amoebic dysentery -- 3.2 Anthrax -- 3.3 Bacillus cereus -- 3.4 Botulism -- 3.5 Brucellosis -- 3.6 Campylobacter -- 3.7 Chickenpox and shingles (varicella-zoster infections) -- 3.8 Chikungunya -- 3.9 Chlamydia pneumoniae -- 3.10 Chlamydia trachomatis -- 3.11 Cholera -- 3.12 CJD and other human transmissible spongiform encephalopathies -- 3.13 Clostridium difficile -- 3.14 Clostridium perfringens -- 3.15 Coronavirus (including MERS and SARS) -- 3.16 Cryptosporidiosis -- 3.17 Cyclosporiasis -- 3.18 Cytomegalovirus -- 3.19 Dengue fever -- 3.20 Diphtheria -- 3.21 Enterococci, including Glycopeptide-Resistant Enterococci (GRE) -- 3.22 Enterovirus infections (including hand, foot and mouth disease) -- 3.23 Epstein-Barr Virus -- 3.24 Giardiasis -- 3.25 Gram-negative bacteraemia (including carbapenem-resistant enterobacteriaceae) -- 3.26 Gonorrhoea, syphilis and other acute STIs -- 3.27 Hantavirus infection -- 3.28 Head lice -- 3.29 Helicobacter pylori -- 3.30 Hepatitis A -- 3.31 Hepatitis B -- 3.32 Hepatitis C -- 3.33 Hepatitis, delta -- 3.34 Hepatitis E -- 3.35 Herpes simplex -- 3.36 Haemophilus influenzae type b (Hib) -- 3.37 HIV -- 3.38 Influenza -- 3.39 Japanese B encephalitis -- 3.40 Legionellosis.
505 8 _a3.41 Leprosy -- 3.42 Leptospirosis -- 3.43 Listeriosis -- 3.44 Lyme disease -- 3.45 Malaria -- 3.46 Measles -- 3.47 Meningococcal infection -- 3.48 MRSA (Meticillin-Resistant Staphylococcus aureus) -- 3.49 Mumps -- 3.50 Mycoplasma pneumoniae infection -- 3.51 Norovirus -- 3.52 Paratyphoid fever -- 3.53 Parvovirus B19 (fifth disease) -- 3.54 Plague -- 3.55 Pneumococcal infection -- 3.56 Poliomyelitis -- 3.57 Psittacosis -- 3.58 Q fever -- 3.59 Rabies -- 3.60 Relapsing fever -- 3.61 Respiratory Syncytial Virus (RSV) -- 3.62 Ringworm -- 3.63 Rotavirus -- 3.64 Rubella -- 3.65 Salmonellosis -- 3.66 Scabies -- 3.67 Schistosomiasis -- 3.68 Shigellosis -- 3.69 Shiga toxin-producing Escherichia coli (STEC) and other diarrhoeagenic E. coli -- 3.70 Smallpox -- 3.71 Staphylococcal food poisoning -- 3.72 Streptococcal infections -- 3.73 Tetanus -- 3.74 Threadworms -- 3.75 Tick-borne Encephalitis -- 3.76 Toxocariasis -- 3.77 Toxoplasmosis -- 3.78 Tuberculosis (and non-tuberculous mycobacteria) -- 3.79 Tularaemia -- 3.80 Typhoid fever -- 3.81 Vibrio parahaemolyticus infection -- 3.82 Viral haemorrhagic fevers, including Ebola -- 3.83 Warts and verrucae (and molluscum contagiosum) -- 3.84 West Nile virus -- 3.85 Whooping cough -- 3.86 Yellow fever -- 3.87 Yersiniosis -- 3.88 Zika virus infection -- 3.89 Other organisms -- 3.89.1 Bacteria -- 3.89.2 Rickettsia, including typhus and ehrlichia -- 3.89.3 Viruses -- 3.89.4 Protozoa -- 3.89.5 Helminths -- 3.89.6 Fungi and actinomycetes -- 3.89.7 Bites, stings, and venoms -- 3.89.8 Chemical food-borne illness -- Section 4 Services and organisations -- 4.1 Surveillance of communicable disease -- 4.2 Managing infectious disease incidents and outbreaks -- 4.3 Community infection control -- 4.4 Hospital infection control -- 4.5 Antimicrobial stewardship -- 4.6 Risks to and from healthcare workers.
505 8 _a4.7 Co-ordination of immunisation services -- 4.8 Co-ordination of sexual health services -- 4.9 Prevention of blood-borne viral infections -- 4.10 Co-ordination of services for tuberculosis control -- 4.11 Travel health -- 4.12 Migrant and refugee health -- 4.13 Emergency preparedness planning and response -- 4.14 Non-infectious environmental hazards -- 4.15 Managing acute chemical incidents -- 4.16 Managing acute radiation incidents -- 4.17 Deliberate release of biological, chemical or radiological hazards -- 4.18 Clinical governance and audit -- 4.19 Global health security -- Section 5 Communicable disease control in Europe -- 5.1 WHO and International Health Regulations -- 5.2 Collaboration within the European Union -- 5.3 Detailed national example: organisational arrangements for health protection, England, 2017 -- 5.4 Austria -- 5.5 Belgium -- 5.6 Bulgaria -- 5.7 Croatia -- 5.8 Cyprus -- 5.9 Czech Republic -- 5.10 Denmark -- 5.11 Estonia -- 5.12 Finland -- 5.13 France -- 5.14 Germany -- 5.15 Greece -- 5.16 Hungary -- 5.17 Iceland -- 5.18 Ireland -- 5.19 Italy -- 5.20 Latvia -- 5.21 Lithuania -- 5.22 Luxembourg -- 5.23 Malta -- 5.24 The Netherlands -- 5.25 Norway -- 5.26 Poland -- 5.27 Portugal -- 5.28 Romania -- 5.29 Slovakia -- 5.30 Slovenia -- 5.31 Spain -- 5.32 Sweden -- 5.33 Switzerland -- 5.34 United Kingdom -- Appendix 1 Guidance documents and books -- Guidance documents and books -- Bloodborne viruses (BBV) -- Immunisation -- Imported infection and travel advice -- Infection control and healthcare acquired infection -- Legionnaires' disease -- Meningitis and meningococcal infection -- Preparedness planning -- Tuberculosis -- Vector-borne diseases -- Other -- Websites containing infectious disease guidelines -- Index -- EULA.
650 0 _aCommunicable diseases.
650 0 _aPublic health
_95696
700 1 _aBegg, Norman.
_eauthor
700 1 _aReintjes, Ralf.
_eauthor
700 1 _aEkdahl, Karl.
_eauthor
700 1 _aEdeghere, Obaghe.
_eauthor
700 1 _avan Steenbergen, Jim E.
_eauthor
856 _uhttps://ebookcentral.proquest.com/lib/atu/detail.action?docID=5612953
_zAccess ebook here
942 _2ddc
_cSG_5
948 _hNO HOLDINGS IN LQI - 1 OTHER HOLDINGS
998 _en
999 _c271223
_d271223